Abstract

Platinum compounds are a group of chemotherapeutic agents included in many pediatric and adult oncologic treatment protocols. The main platinum compounds are cisplatin, carboplatin, and oxaliplatin. Their use in clinical practice has greatly improved long-term survival of pediatric patients, but they also cause some toxic effects: ototoxicity, myelosuppression, nephrotoxicity, and neurotoxicity. Hearing damage is one of the main toxic effects of platinum compounds, and it derives from the degeneration of hair cells of the ear, which, not having self-renewal capacity, cannot reconstitute themselves. Hearing loss from platinum exposure is typically bilateral, sensorineural, and permanent, and it is caused by the same mechanisms with which platinum acts on neoplastic cells. According to available data from the literature, the optimal timing for the audiological test during and after treatment with platinum compounds is not well defined. Moreover, no substances capable of preventing the onset of hearing loss have been identified.

Highlights

  • Platinum compounds are a group of chemotherapeutic agents included in many pediatric and adult oncologic treatment protocols

  • Platinum compounds represent a cornerstone in the treatment of many different childhood cancer types, and their use has dramatically improved survival

  • They can determine toxic effects including hearing damage, which is an important problem for patients in the pediatric age group

Read more

Summary

Introduction

Platinum compounds are a group of chemotherapeutic agents included in many pediatric and adult oncologic treatment protocols. The main platinum compounds are cisplatin, carboplatin, and oxaliplatin. They exert their action by covalent binding to purine DNA bases, resulting in interference with normal DNA function [2,3]. Oxaliplatin is able to penetrate erythrocytes and remains there longer than in plasma On this basis, O’Dwyer et al (2000) reported that red blood cells can probably represent a drug reservoir [5,19]. Carboplatin, and oxaliplatin are all compounds obtained from platinum and have some similar pharmacodynamic characteristics; they each present specific antineoplastic activity and are used in different treatment protocols for tumors both of pediatric and adult population

Pathogenesis of Hearing Damage from Platinum Compounds
Assessment of the Hearing Function during Treatment with Platinum Compounds
Audiological Follow-Up after Therapy with Platinum Compounds
Strategies of Prevention of Hearing Loss
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.